We are live on ! Find out more
SL

Summitry LLC Portfolio holdings

AUM $3.04B
1-Year Est. Return 17.05%
This Fund
S&P 500
This Quarter Est. Return
-12.56%
1 Year Est. Return
+17.05%
3 Year Est. Return
+68.13%
5 Year Est. Return
+77.78%
10 Year Est. Return
+281.24%
AUM
$1.02B
AUM Growth
-$150M
Cap. Flow
+$11.8M
Cap. Flow %
1.15%
Top 10 Hldgs %
46.32%
Holding
87
New
7
Increased
43
Reduced
17
Closed
10

Top Sells

Rank Stock Value
1
ENOV icon
Enovis
ENOV
+$21.2M
2
FLS icon
Flowserve
FLS
+$12.1M
3
NVS icon
Novartis
NVS
+$5.11M
4
AGN
Allergan plc
AGN
+$3.94M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$2.3M

Sector Composition

Rank Sector Weight
1 Financials 20.59%
2 Miscellaneous 18.04%
3 Technology 15.26%
4 Healthcare 15.22%
5 Industrials 10.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
1
Berkshire Hathaway Class B
BRK.B
$1.08T
$73.5M 7.18%
359,764
-11,030
-3% -$2.3M
IGSB icon
2
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
$63.1M 6.17%
1,222,306
+320
+0% +$16.5K
TIP icon
3
iShares TIPS Bond ETF
TIP
$15B
$50.5M 4.93%
461,226
-816
-0.2% -$89.1K
FLS icon
4
Flowserve
FLS
$10.2B
$43.7M 4.27%
1,150,440
-259,446
-18% -$12.1M
AGN
5
DELISTED
Allergan plc
AGN
$43.3M 4.23%
324,184
-24,040
-7% -$3.94M
MSFT icon
6
Microsoft
MSFT
$3.81T
$41.4M 4.04%
407,156
-16,528
-4% -$1.77M
CTSH icon
7
Cognizant
CTSH
$28.8B
$40.4M 3.95%
637,013
+107,019
+20% +$7.44M
AGG icon
8
iShares Core US Aggregate Bond ETF
AGG
$138B
$39.8M 3.89%
373,527
+4,294
+1% +$450K
META icon
9
Meta Platforms (Facebook)
META
$1.47T
$39.3M 3.84%
299,978
+51,730
+21% +$7.49M
AAPL icon
10
Apple
AAPL
$4.67T
$39.1M 3.82%
991,800
+182,420
+23% +$8.84M
GOOGL icon
11
Alphabet (Google) Class A
GOOGL
$4.24T
$38.3M 3.74%
733,280
+50,580
+7% +$2.73M
V icon
12
Visa
V
$712B
$38.3M 3.74%
290,070
+11,933
+4% +$1.65M
LH icon
13
Labcorp
LH
$27.2B
$37.8M 3.69%
348,176
+136,922
+65% +$18.3M
BAC icon
14
Bank of America
BAC
$436B
$37.2M 3.63%
1,509,581
+342,493
+29% +$9.29M
OI icon
15
O-I Glass
OI
$1.14B
$36.8M 3.59%
2,133,035
-61,239
-3% -$1.07M
BNY
16
Bank of New York Mellon
BNY
$110B
$34.8M 3.4%
739,983
+166,452
+29% +$8.08M
NVS icon
17
Novartis
NVS
$292B
$34.5M 3.37%
449,036
-65,631
-13% -$5.11M
MDT icon
18
Medtronic
MDT
$117B
$32.3M 3.15%
354,717
-11,041
-3% -$1.03M
EXPE icon
19
Expedia Group
EXPE
$39.5B
$29.9M 2.93%
265,858
-7,786
-3% -$932K
LQD icon
20
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.9B
$29.1M 2.85%
258,236
+1,173
+0.5% +$132K
FISV
21
Fiserv Inc
FISV
$28.3B
$27.3M 2.66%
370,831
-10,980
-3% -$849K
C icon
22
Citigroup
C
$223B
$22M 2.15%
421,963
-2,550
-0.6% -$161K
DE icon
23
Deere & Co
DE
$170B
$20.2M 1.97%
135,253
-364
-0.3% -$53.3K
DIS icon
24
Walt Disney
DIS
$187B
$19.9M 1.95%
181,783
-1,286
-0.7% -$146K
GE icon
25
GE Aerospace
GE
$355B
$19.9M 1.94%
548,597
-39,952
-7% -$1.8M

Similar funds

Summitry LLC's Q4 2018 Portfolio in Review

As of Q4 2018, Summitry LLC held 87 positions worth $1.02B, down 13% from $1.17B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Summitry LLC's Q4 2018 filing shows 7 new, 43 increased, 17 reduced and 10 closed positions. Its largest new stake was Vanguard Short-Term Corporate Bond ETF: 7,157 shares worth $558K. The largest sale was Enovis, an estimated $21.2M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Technology.

  • Summitry LLC's largest Q4 2018 buy was Vanguard Short-Term Corporate Bond ETF: 7,157 shares worth $558K.
  • Summitry LLC added most to Labcorp in Q4 2018, an estimated $18.3M increase.
  • Summitry LLC's biggest Q4 2018 reduction was Flowserve, cutting an estimated $12.1M.
  • Summitry LLC fully exited Enovis in Q4 2018, selling an estimated $21.2M.
  • Summitry LLC's ten largest holdings make up 46% of its $1.02B portfolio in Q4 2018.
  • Summitry LLC opened 7 new positions and closed 10 in Q4 2018.
  • Summitry LLC's portfolio value fell 13% quarter-over-quarter to $1.02B.

Based on Summitry LLC's 13F filing for Q4 2018, filed 8 Feb 2019.